Skip to main content
logo
Herantis Pharma Oyj (HEL:HRTIS)
Finland flag Finland · Delayed Price · Currency is EUR
1.650
+0.030 (1.85%)
Aug 28, 2026, 6:29 PM EET

Herantis Pharma Oyj Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-6.5-6.4-5.030.15-7.99-12.46
Net Income
-6.74-6.62-4.940.28-9.32-12.77
Earnings Per Share
-0.27-0.28-0.240.02-0.64-1.25
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.512.62.136.495.997.42
Total Debt
0.020.070.030.034.547.33
Net Cash (Debt)
3.492.532.16.451.450.09
Net Cash Growth
37.87%20.10%-67.39%345.14%1482.98%-98.50%
Net Cash Per Share
0.140.110.100.380.100.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.04-6.1-6.55-4.64-8.94-9.93
Capital Expenditures
------
Free Cash Flow
-6.04-6.1-6.55-4.64-8.94-9.93
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---113.47--
Forward PE
-1.121.121.121.121.12
PS Ratio
------